Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC
Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins LACE Partners’ podcast to raise awareness of TNBC and spark vital conversations about how workplaces can better support those affected.
The Patient Voice helps guide BioNTech design for UK Drug Trial
The UK Charity for Triple Negative Breast Cancer (TNBC) recently asked our Patient Advisory Panel (PAP) members a series of important questions on behalf of the pharmaceutical company BioNTech. Their answers provided critical information which will now be used by BioNTech to help inform the design of a trial for an investigational drug intended for people with the metastatic form of TNBC.
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC
New NICE guidance on TNBC treatment reflects input from The UK Charity for TNBC’s Patient Advisory Panel (PAP). Your involvement is helping to shape more effective care for those affected by TNBC.
Report from ESMO Breast 2025
The UK Charity for TNBC attended ESMO Breast 2025 in Munich, presenting a poster, ‘Needs of People with Triple Negative Breast Cancer (TNBC): The Patients Voice’, based on roundtable discussions in partnership with RCNi, produced by Dr Hira Yousef and Professor Chris Twelves.
Make 2nds Count can help find a trial for you!
Make 2nds Count has relaunched its free clinical trials service, helping secondary breast cancer patients, including those with triple negative breast cancer, find suitable trials. This nurse-led support offers expert guidance and tailored searches.
Government Recognises That TNBC Needs A Specific Approach
Recently in parliament, government representatives recognised that a cancer specific approach is needed to meet the challenges in cancer care and to improve outcomes for people living with triple negative breast cancer.
We are looking for more TNBC CHAMPIONS!
Apply now for the free TNBC Study Day on 21st March 2025 in London. Limited to 25 places, this CPD-certified event is your chance to become a TNBC Nurse Champion. Educate, engage, and lead as the expert in your team. Apply via RCNi today!
Keytruda (Pembroluzimab) Positive Results!
Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients
The UK Charity for TNBC Becomes NICE Stakeholder
The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.
Education Grants for Nurses!
The UK Charity for Triple Negative Breast Cancer is delighted to be announcing a Foundation to provide grants to fund further education for individual breast cancer nurses.
The UK Charity for TNBC Appears on BOPA Podcast
Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.